SBIR Phase I: Double-Sided Advertising Exchange
SBIR 第一阶段:双面广告交换
基本信息
- 批准号:1215401
- 负责人:
- 金额:$ 15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-01 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This Small Business Innovation Research (SBIR) Phase I project seeks to develop and validate a real-time, double-sided auction framework AdEx, for intelligent advertisements. This system significantly increases the likelihood of more relevant matches at a lower cost between consumers and advertisers, buyers and sellers. The key innovation is to directly utilize user-purchasing and interest profiles, culled from aggregated exchange data and social networking information, and use this data to create fungible trading objects. Aggregating groups of these objects with similar interests and profiles will enable real-time bidding for both the producer and consumer of advertising over a multi-variable bidding space. Configured as a dynamic exchange, AdEx facilitates three novel functionalities: 1) double-sided dynamic bidding; 2) allows dual programmable trading agents for optimized marketing; and 3) auctions would be cleared and use linear programming to assess the outcome. Thus allowing synthetic liquidity generation, and interconnection between disparate advertising networks with commission sharing resulting in more efficient markets. This double-sided advertising exchange, a component of MetaNet's vision of efficient interconnected enterprise social extranets, will form the fabric for the next growth phase of the Information Revolution allowing corporations to connect with customers and collaborate with trusted partners in remarkable new ways.The broader impact/commercial potential of this project will be the facilitation of more efficient automated markets, which will transform advertising and direct marketing. The new revenue models possible, based on knowing more about who will be communicating with and why, are vast. The search engine industry was able to connect any user to any other user on the web. Eventually, both types of connections will combine with impact to marketing ROI. Currently the launch of a new consumer brand could cost between $10-100 million, with most of this spent on advertising. MetaNet?s vision could reduce the cost of launching a new brand disruptively by enabling a revolution in the ease-of-launching new products and businesses. If deployed universally, it could enable a reduction of friction causing a dramatic rise in global productivity. Finally, as spam overtakes our Inboxes and Facebook updates, signal-to-noise ratio for electronic communication is dropping. This innovation is designed to improve the ability to target consumers intelligently, and thus, may be the seed for a new communications eco-system that could someday eliminate spam.
这个小型企业创新研究(SBIR)第一阶段项目旨在开发和验证用于智能广告的实时、双面拍卖框架ADEX。这一系统大大增加了消费者与广告商、买家和卖家之间以较低成本进行更相关匹配的可能性。关键的创新是直接利用从汇总的交易所数据和社交网络信息中挑选出来的用户购买和兴趣档案,并使用这些数据创建可替换的交易对象。将具有相似兴趣和配置文件的这些对象的组聚合在一起,将使广告生产者和消费者能够在多变量竞价空间上进行实时竞价。作为一种动态交易所,ADEX提供了三种新的功能:1)双边动态竞价;2)允许两个可编程的交易代理进行优化营销;以及3)拍卖将被清算,并使用线性规划来评估结果。因此,允许综合产生流动性,并通过佣金分享在不同的广告网络之间建立互联,从而产生更有效的市场。这种双边广告交换是Metanet关于高效互连的企业社交外联网愿景的组成部分,它将为信息革命的下一个增长阶段奠定基础,使公司能够以非凡的新方式与客户联系并与值得信赖的合作伙伴合作。该项目的更广泛的影响/商业潜力将是促进更高效的自动化市场,这将改变广告和直接营销。基于更多地了解谁将与谁沟通以及为什么沟通,可能出现的新收入模式是巨大的。搜索引擎行业能够将任何用户与网络上的任何其他用户联系起来。最终,这两种类型的联系都将与对营销ROI的影响结合在一起。目前,推出一个新的消费品牌的成本可能在1000万至1亿美元之间,其中大部分花在广告上。Metanet?S的愿景可以通过在易于推出新产品和业务方面实现一场革命,来降低颠覆性推出新品牌的成本。如果在全球普遍部署,它可以减少摩擦,导致全球生产率大幅提高。最后,随着垃圾邮件取代我们的收件箱和Facebook更新,电子通信的信噪比正在下降。这项创新旨在提高智能定位消费者的能力,因此,可能成为有朝一日消除垃圾邮件的新通信生态系统的种子。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Moses Ma其他文献
Putting a human face on cyberspace (panel): designing avatars and the virtual worlds they live in
将人脸置于网络空间(小组):设计化身及其生活的虚拟世界
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:0
- 作者:
B. Damer;Steve Di Paola;Joannis Paniaras;Kirk Parsons;Bernie Roel;Moses Ma - 通讯作者:
Moses Ma
Putting a human face on cyberspace: designing avatars and the virtual worlds they live in (panel).
在网络空间中展现人性:设计化身及其生活的虚拟世界(小组)。
- DOI:
10.1145/258734.258909 - 发表时间:
1997 - 期刊:
- 影响因子:0
- 作者:
B. Damer;Steve Di Paola;Joannis Paniaras;Kirk Parsons;Bernie Roel;Moses Ma - 通讯作者:
Moses Ma
Moses Ma的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark
Supercooled Phase Transition
- 批准号:24ZR1429700
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
ATLAS实验探测器Phase 2升级
- 批准号:11961141014
- 批准年份:2019
- 资助金额:3350 万元
- 项目类别:国际(地区)合作与交流项目
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
- 批准号:41802035
- 批准年份:2018
- 资助金额:12.0 万元
- 项目类别:青年科学基金项目
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究
- 批准号:61675216
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Phase-type分布的多状态系统可靠性模型研究
- 批准号:71501183
- 批准年份:2015
- 资助金额:17.4 万元
- 项目类别:青年科学基金项目
纳米(I-Phase+α-Mg)准共晶的临界半固态形成条件及生长机制
- 批准号:51201142
- 批准年份:2012
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
连续Phase-Type分布数据拟合方法及其应用研究
- 批准号:11101428
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
D-Phase准晶体的电子行为各向异性的研究
- 批准号:19374069
- 批准年份:1993
- 资助金额:6.4 万元
- 项目类别:面上项目
相似海外基金
Pro-Resolving Inflammatory Mediators in Neurovascular Gains in Aerobic Training; a phase 2, double-blind, randomized placebo-controlled trial (PRIMiNG-AT2)
有氧训练中促进神经血管增益的炎症介质的消除;
- 批准号:
485524 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Operating Grants
A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis
一项 2 期、随机、双盲、4 组、多中心研究,旨在证明处方药局部剂量制剂治疗光化性角化病的有效性和安全性
- 批准号:
10820810 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial
高压氧治疗因中度至重度发作而住院的溃疡性结肠炎患者:一项 3 期多中心、随机、双盲、假对照试验
- 批准号:
10561414 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Basic research to develop fiber-reinforced double-phase alloys with lightweight and high-electrical conductivity
开发轻质高导电纤维增强双相合金的基础研究
- 批准号:
22H01825 - 财政年份:2022
- 资助金额:
$ 15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The Safety and Efficacy of Adalimumab for Pain Reduction in Individuals with Mucopolysaccharidoses: A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial
阿达木单抗用于减轻粘多糖症患者疼痛的安全性和有效性:1/2 期随机、双盲、安慰剂对照试验
- 批准号:
474611 - 财政年份:2022
- 资助金额:
$ 15万 - 项目类别:
Operating Grants
Does phase-separation of DNA double-strand break repair factors promote chromosome rearrangement?
DNA双链断裂修复因子的相分离是否促进染色体重排?
- 批准号:
22K12376 - 财政年份:2022
- 资助金额:
$ 15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ZZ-3K3A-301: A multicenter, randomized, placebo-controlled, double-blinded, Phase 3 study to evaluate the efficacy and safety of 3K3A-APC (RHAPSODY-2)
ZZ-3K3A-301:一项多中心、随机、安慰剂对照、双盲、3 期研究,旨在评估 3K3A-APC (RHAPSODY-2) 的有效性和安全性
- 批准号:
10305528 - 财政年份:2022
- 资助金额:
$ 15万 - 项目类别:
A Phase II/III randomized, placebo controlled, double blind study to evaluate the effects of up to 24 weeks of low dose pazopanib on HHT related epistaxis and anemia. IND#144808 June 25, 2020
一项 II/III 期随机、安慰剂对照、双盲研究,旨在评估长达 24 周的低剂量帕唑帕尼对 HHT 相关鼻出血和贫血的影响。
- 批准号:
10281794 - 财政年份:2022
- 资助金额:
$ 15万 - 项目类别:
The Safety and Efficacy of Adalimumab for Pain Reduction in Individuals with Mucopolysaccharidoses: A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial
阿达木单抗用于减轻粘多糖症患者疼痛的安全性和有效性:1/2 期随机、双盲、安慰剂对照试验
- 批准号:
474599 - 财政年份:2022
- 资助金额:
$ 15万 - 项目类别:
Operating Grants